Caspofungin acetate

INDICATIONS

FDA

  • Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other anti-fungal therapy.
  • Esophageal candidiasis (authors’ opinion: would reserve caspofungin for azole-resistant cases).
  • Empiric treatment of presumed fungal infections in febrile neutropenic patients.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: May 1, 2017